Open Hemorrohoidectomy Vs Transanal Hemorrhoidal Desarterialization in Hemorrhoids Grade III: The Effect on Symptoms
Launched by HOSPITAL SON LLATZER · May 15, 2024
Trial Information
Current as of March 13, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • Age older than 18.
- • Hemorroids grade III.
- • Surgical indication for hemorroid treatment.
- • Signed informed consent.
- Exclusion criteria:
- • Acute hemorroidal disease.
- • Previous hemorroidal surgery.
- • Concomitant anal fissure.
- • Concomitant perianal fistulae.
- • Concomitant rectal prolapse.
- • Inflamatory bowel disease.
- • Anal or colorrectal cancer.
About Hospital Son Llatzer
Hospital Son Llatzer is a leading healthcare institution located in Mallorca, Spain, dedicated to providing high-quality medical care and advancing clinical research. As a prominent clinical trial sponsor, the hospital focuses on innovative therapeutic approaches and evidence-based practices, fostering collaboration among multidisciplinary teams to enhance patient outcomes. With state-of-the-art facilities and a commitment to ethical standards, Hospital Son Llatzer actively participates in the development of novel treatments and contributes to the global medical community through rigorous clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Palma De Mallorca, Illes Balears, Spain
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
